Searchable abstracts of presentations at key conferences in endocrinology

ea0089b2 | Basic Science | NANETS2022

Multiple Layers of Epigenetic Regulation Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors

Madigan James P. , Sharma Rupali , Mondell Ethan , Sadowski Samira M.

Background: Pancreatic neuroendocrine tumors (P-NETs) are a rare cancer with increasing incidences worldwide. Low-grade P-NETs are unique in that they express high levels of Somatostatin Receptor Type 2 (SSTR2), which represents a target for both tumor imaging and therapeutics. P-NET grade inversely correlates with SSTR2 tumor staining, and higher tumor grade is associated with poor patient prognosis. Unfortunately, application of SSTR2-targeted treatment options is currently ...

ea0024oc4.1 | Oral Communications 4 (Brief Communications) | BSPED2010

Cyclical variation in the incidence of type 1 diabetes in children from northeast England

McNally R , Court S , James P , Pollock R , Blakey K , Begon M , Cheetham T

Background: Environmental factors play a role in the aetiology of type 1 diabetes. A particular role for infectious exposures has been postulated. Temporal variation in incidence would be consistent with this hypothesis. We specifically aimed to test predictions of increasing incidence occurring among cases of type 1 diabetes in children (aged 0–14 years) that might arise as a result of an environmental mechanism.Subjects and methods: The study anal...

ea0098b27 | Basic Science | NANETS2023

Development of GEP-NEN patient derived organoids for therapy screening

Forsythe Steven D. , Madigan James P. , Andrews Stephen , del Rivero Jaydira , Hernandez Jonathan M. , Nilubol Naris , Sadowski Samira M.

Background: Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs) are a rare subset of cancers which nevertheless are a rising health burden. Development of new therapies suffers from several bottlenecks, including low patient accrual and poor understanding of tumor characteristics. Patient tumor organoids (PTOs) are a novel model capable of improving screening of patient tissue in an accurate, standardized, and high-throughput capacity. In this study, we utilized patient...

ea0030oc2.8 | Oral Communications 2 | BSPED2012

Genetic screening in a large cohort of patients with congenital hypopituitarism; current knowledge and future directions

Alatzoglou Kyriaki S , Turton James P G , Kelberman Daniel , McCabe Marc J , Gregory Louise C , Webb Emma A , McNay David E G , Woods Kathryn S , Mehta Ameeta , Dattani Mehul T

Background and aims: Congenital hypopituitarism (CH) encompasses a spectrum of phenotypes. Known genetic factors account for variable percentage of cases depending on the cohort screened. We analysed the results of genetic screening in a large cohort of patients with CH with the following aims: i) to clarify the genetic aetiology of CH ii) identify any phenotype genotype correlations and iii) propose a screening strategy.Patients and methods: Over 15 yea...